Within Our Reach: Finding a Cure for Rheumatoid Arthritis

Within Our Reach-funded Study Finds Increased Depression Risk Among Certain Populations of RA Patients
Within Our Reach in the News > Study Finds Increased Depression Risk Among RA Patients


Edward H. Yelin,
PhD

A study recently published in Arthritis & Rheumatism found that patients with rheumatoid arthritis from multiethnic backgrounds have nearly double the rate of depressive symptoms compared with middle-class white patients with RA. The study also examined predictors of depression, and concluded that physical disability—not acute disease activity—is the principal predictor of depression in patients with RA.

RA is a chronic disease that causes pain, stiffness, swelling, and limitation in the motion and function of multiple joints. Disability occurs when a patient can no longer perform a task they once could, while acute RA disease activity is measured by swollen joints, tender joints, and inflammatory markers in patient assessments.

The study followed 172 patients at San Francisco General Hospital’s outpatient rheumatology clinic and found that 40 percent of this multiethnic, low-income cohort had symptoms of at least moderate depression. However, Asian patients had lower scores compared with other patients in the cohort.

The research also shows that patients can tolerate symptoms such as swelling and tenderness without becoming depressed. However, when patients can no longer perform certain tasks because of disability, many develop depressive symptoms. Based on these findings, the researchers concluded that rheumatologists should continue to make disability prevention a priority through their treatment choices and should encourage additional screening for depression, especially in at-risk populations.

Among the researchers on this project were Edward Yelin, PhD, professor in residence of medicine and health policy in the Division of Rheumatology, and Mary Margaretten, MD, assistant adjunct professor of medicine, both of whom are at the University of California, San Francisco.

Dr. Yelin—a recent recipient of an ACR Research and Education Foundation’s Within Our Reach: Finding a Cure for Rheumatoid Arthritis RA research grant—says, “I think what was shocking is that the rate is twice as high in one group versus another. When that happens, you would think that it would be driven by different factors, but it seems to be driven by the same ones, including disability and age.”

Dr. Margaretten believes the study’s findings demonstrate why it’s important for practicing rheumatologists to screen for depression—especially in patients from diverse ethnic backgrounds and with lower socioeconomic status. The study also provides further evidence of the benefit of staving off disability as long as possible. “Disability certainly has psychological consequences,” she says.

Dr. Yelin notes that future research might seek to understand why Asian patients—despite severe disease and low socioeconomic status—report less depression. “Is it because they are more stoic?” he asks. “Do the measures we use not work as well for them? Do they have more cultural support?” An estimated 1.3 million Americans have RA, and the disease typically affects women twice as often as men. Patients with depression have more RA-related physician visits and hospitalizations. They are also more likely to discontinue use of medications and anti-tumor necrosis factor–??therapy compared to patients without depression, according to the study.

Arthritis and Rheumatism vol. 61, no. 11, pgs. 1586-1591, 11/15/09, "Predictors of Depression in a Multiethnic Cohort of Patients With Rheumatoid Arthritis", M. MARGARETTEN, E. YELIN, J. IMBODEN, J. GRAF, J. BARTON, P. KATZ,AND L. JULIAN

 

 

 

 

Home Contact Us Learn About RA Research Donate to Rheumatoid Arthritis Research Learn About RA

Keep me Informed